Physician profile
Samit Patel
NPI 1144661083
$912.18
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $300.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $111.37 | 2019-2020 | |
| Novo Nordisk INC | $83.31 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $80.61 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $59.88 | 2019-2020 | |
| Glaxosmithkline, LLC. | $57.31 | 2019-2020 | |
| Allergan, INC. | $57.00 | 2019 | |
| Amgen INC. | $53.92 | 2019-2020 | |
| Astellas Pharma US INC | $52.09 | 2019-2020 | |
| Lilly USA, LLC | $46.80 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $40.37 | 2019-2020 | |
| Pfizer INC. | $34.20 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $29.74 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.39 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.41 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $22.57 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.39 | 2019 | |
| Philips North America LLC | $19.02 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $17.12 | 2019 | |
| Amarin Pharma, INC. | $16.54 | 2019 | |
| Sanofi Pasteur INC. | $16.53 | 2019 | |
| Daiichi Sankyo INC. | $16.37 | 2020 | |
| Shire North American Group INC | $12.39 | 2019 | |
| Eisai INC. | $11.85 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.